Muscular dystrophy refers to a group of more than 30 inherited (genetic) diseases that cause muscle atrophy weakness.
Over time, muscles shrink and become weaker, affecting the ability to walk and perform daily activities
Some types may affect the heart and respiratory function.
Some forms of muscular dystrophy are apparent during childhood like the Duchenne (DMD) and some other forms develop later during adulthood like cases of Limb-Girdle Muscular Dystrophy (LGMD).
AR LGMD is common in Egypt and this is due to the high consanguinity rate estimated as more than 30%.
Currently, there are several promising ongoing clinical trials for some types which changed our approach towards muscular dystrophy.
Standards of care with multidisciplinary care is crucial for a better quality of life for patients living with muscular dystrophy and to avoid common complications like joint contractures, scoliosis, and heart or respiratory failure.
In the era of gene modifying and mutation-specific therapies, genetic testing is considered a key for all muscular dystrophy patients, it’s not acceptable anymore to use muscular dystrophy as the final diagnosis.
Myo-Care Foundation provides experts dedicated to providing international standards of care for muscular dystrophy patients in Egypt.